Citations

Showing 10 of 107969 citations.

Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy
Morris, George L. , Gloss, David , Buchhalter, Jeffrey , Mack, Kenneth J. , Nickels, Katherine , Harden, Cynthia L., Nickels, Katherine C

Mayo Clinic

Neurology | August 29, 2013 | Volume: 81 | Issue: 16 | Pages: 1453-1459

10.1212/wnl.0b013e3182a393d1 | PMID 23986299 Get It

Detection and Identification of Yeasts from Formalin-Fixed, Paraffin-Embedded Tissue by Use of PCR-Electrospray Ionization Mass Spectrometry
Simner, Patricia J. , Buckwalter, Seanne P., Uhl, James R., Wengenack, Nancy L. , Pritt, Bobbi S. , Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | August 29, 2013 | Volume: 51 | Issue: 11 | Pages: 3731-3734

10.1128/jcm.01967-13 | PMID 23985922 Get It

ABSTRACT Diagnosis of yeast infection is typically accomplished by fungal smear and culture, histopathologic examination, and/or serologic studies. Newer assays based on mass spectrometry may be useful for yeast identification when histologic examination is inconclusive, fungal cultures are not ordered, or cultures fail to yield a causative agent. The purpose of this study was to evaluate the ability of the PLEX-ID broad fungal assay to accurately detect and identify yeasts in formalin-fixed paraffin-embedded (FFPE) tissues. Tissue samples from 78 FFPE specimens with both histopathology and corresponding culture results for a variety of yeasts were tested using the PLEX-ID broad fungal assay. A 40-μm FFPE tissue section from each specimen was digested with proteinase K followed by nucleic acid extraction and PCR using broad-range fungal primers. Yeast DNA in amplified products was identified using electrospray ionization mass spectrometry. Discordant results were resolved by D2 rRNA gene sequencing. PLEX-ID analysis detected yeast DNA in 78.2% (61/78) of the cases, of which 91.8% (56/61) were concordant with culture results. Of the 5 discordant positive results, 4 PLEX-ID results were considered to result from environmental contaminants, while 1 clinically important discrepancy was observed ( Blastomyces dermatitidis by culture and Cryptococcus neoformans by PLEX-ID). Sequencing of the discordant sample was unsuccessful. The majority of histopathology results (89.7% [70/78]) correlated with culture results. The PLEX-ID broad fungal assay identifies fungi directly from FFPE tissues and can be a useful adjunct to traditional culture and histopathology tests.
Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics
Gibbons, Simon J. , Verhulst, Pieter–Jan, Bharucha, Adil E. , Farrugia, Gianrico , Gibbons, S J

Mayo Clinic

Alimentary Pharmacology & Therapeutics | August 29, 2013 | Volume: 38 | Issue: 7 | Pages: 689-702

10.1111/apt.12467 | PMID 23992228 Get It

An essential role for Rab27a GTPase in eosinophil exocytosis
Kim, John Dongil, Willetts, Lian, Ochkur, Sergei I. , Srivastava, Nutan, Hamburg, Rudolf, Shayeganpour, Anooshirvan, Seabra, Miguel C. , Lee, James J. , Moqbel, Redwan, Lacy, Paige

Mayo Clinic

Journal of Leukocyte Biology | August 29, 2013 | Volume: 94 | Issue: 6 | Pages: 1265-1274

10.1189/jlb.0812431 | PMID 23986549 Get It

ABSTRACT Eosinophil degranulation has been implicated in inflammatory processes associated with allergic asthma. Rab27a, a Rab-related GTPase, is a regulatory intracellular signaling molecule expressed in human eosinophils. We postulated that Rab27a regulates eosinophil degranulation. We investigated the role of Rab27a in eosinophil degranulation within the context of airway inflammation. Rab27a expression and localization in eosinophils were investigated by using subcellular fractionation combined with Western blot analysis, and the results were confirmed by immunofluorescence analysis of Rab27a and the granule membrane marker CD63. To determine the function of eosinophil Rab27a, we used Ashen mice, a strain of Rab27a-deficient animals. Ashen eosinophils were tested for degranulation in response to PAF and calcium ionophore by measuring released EPX activity. Airway EPX release was also determined by intratracheal injection of eosinophils into mice lacking EPX. Rab27a immunoreactivity colocalized with eosinophil crystalloid granules, as determined by subcellular fractionation and immunofluorescence analysis. PAF induced eosinophil degranulation in correlation with redistribution of Rab27a+ structures, some of which colocalized with CD63+ crystalloid granules at the cell membrane. Eosinophils from mice had significantly reduced EPX release compared with normal WT eosinophils, both in vitro and in vivo. In mouse models, Ashen mice demonstrated reduced EPX release in BAL fluid. These findings suggest that Rab27a has a key role in eosinophil degranulation. Furthermore, these findings have implications for Rab27a-dependent eosinophil degranulation in airway inflammation.
The SYCL Toolkit: Creating a Program within a Professional Organization for Young Scientists
McCudden, Christopher R. , Cervinski, Mark A , Grenache, David G., Haymond, Shannon, Korpi‐Steiner, Nichole , Molinaro, Ross J., Saenger, Amy K., Cervinski, Mark A

Mayo Clinic

Clinical Chemistry | August 28, 2013 | Volume: 59 | Issue: 9 | Pages: 1416-1417

10.1373/clinchem.2013.211011 | PMID 24137752 Get It

High data rate transmission of medical images - Prospectus for experiments using the NASA Advanced Communications Technology Satellite
Khandheria, Bijoy K. , Mitchell, Marvin L., Gilbert, Barry K., Bengali, Abdul, Garratt, Kirk N. , Holmes, David R. , Wood, Michael B., Bengali, Abdul R.

Mayo Clinic

16th International Communications Satellite Systems Conference | August 28, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.2514/6.1996-1071 Get It

From Metabolic Pathways To Biomarkers: Where Are We Now With Metabolomics In Alzheimer‘s Disease?
Trushina, Eugenia , Trushina, Eugenia

Mayo Clinic

Future Neurology | August 28, 2013 | Volume: 8 | Issue: 5 | Pages: 491-494

10.2217/fnl.13.36 Get It

Use of thoracic radiation therapy for small-cell lung cancer
Schild, Steven E.

Mayo Clinic

Personalized Management of Lung Cancer | August 28, 2013 | Volume: No volume available | Issue: No issue available | Pages: 114-128

10.2217/ebo.12.157 Get It

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
Pidala, Joseph, Wang, Tao , Haagenson, Michael , Askar, Medhat , Baxter‐Lowe, Lee Ann , Bitan, Menachem, Fernández-Viña, Marcelo , Jakubowski, Ann A. , Maiers, Martin , Marino, Susana R. , Oudshoorn, Machteld, Palmer, Jeanne , Prasad, Vinod K. , Reddy, Vijay , Ringdén, Olle , Saber, Wael , Santarone, Stella , Schultz, Kirk R. , Setterholm, Michelle, Trachtenberg, Elizabeth, Turner, E. Victoria, Woolfrey, Ann E. , Lee, Stephanie J. , Anasetti, Claudio , Spellman, Stephen R. , Battiwalla, Minoo , Gandhi, Manish J. , Marsh, Steven G. E. , Ringden, Olov , Lee, Stephanie J , Maiers, Martin

Mayo Clinic

Blood | August 28, 2013 | Volume: 122 | Issue: 22 | Pages: 3651-3658

10.1182/blood-2013-05-501510 | PMID 23982174 Get It

Key PointsAmino acid substitution at peptide-binding residues of the HLA class I molecule is associated with graft-versus-host disease and mortality. Avoidance of donor-recipient combinations that result in amino acid substitution at peptide-binding residues may improve transplant outcomes.
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
Xu‐Monette, Zijun Y. , Møller, Michael , Tzankov, Alexandar , Montes‐Moreno, Santiago , Hu, Wenwei , Manyam, Ganiraju C. , Kristensen, Louise , Fan, Lei , Visco, Carlo , Dybkær, Karen , Chiu, April , Tam, Wayne , Zu, Youli , Richards, Kristy L. , Choi, William W.L., Krieken, J. Han van , Huang, Qin , Huh, Jooryung , Ferreri, Andrés J.M. , Zhao, Xiaoying , Bueso‐Ramos, Carlos E. , Wang, Sa A. , Winter, Jane N. , Piris, Miguel Á. , Medeiros, L. Jeffrey , Young, Ken H. , Bhagat, Govind , Hsi, Eric D. , Ai, Weiyun Z. , Ponzoni, Maurilio , Wu, Lin , Go, Ronald S. , Li, Yong , Møller, Michael Boe , Winter, Jane N , Tzankov, Alexandar , Dybkaer, Karen , van Krieken, J Han , Young, Ken H , Piris, Miguel , Medeiros, L Jeffrey , Zu, Youli , Montes-Moreno, Santiago , Xu-Monette, Zijun Y

Mayo Clinic

Blood | August 28, 2013 | Volume: 122 | Issue: 15 | Pages: 2630-2640

10.1182/blood-2012-12-473702 | PMID 23982177 Get It

Key PointsPhenotypic and genotypic profiling of MDM2 in DLBCL. MDM2 as a negative regulator of p53 tumor suppressor function.